Skip to main content
Boryung Corporation logo

Boryung Corporation — Investor Relations & Filings

Ticker · 003850 ISIN · KR7003850005 KO Manufacturing
Open in API
Filings indexed 354 across all filing types
Latest filing 2026-06-01 Report Publication Anno…
Country KR South Korea
Listing KO 003850

About Boryung Corporation

https://pharm.boryung.co.kr/eng/index.do

Boryung Corporation is a fully integrated healthcare company founded in 1957. Its core business encompasses the research, development, manufacturing, and global commercialization of pharmaceutical products, with a significant presence in the cardiovascular therapeutic area. The company is distinguished by its pioneering 'Care in Space' (CIS) initiative, which focuses on developing healthcare solutions for humans in extreme environments and leveraging space for new research opportunities. In addition to its pharmaceutical operations, Boryung functions as a healthcare investment company, fostering innovation across the health sector. The company's diverse portfolio includes prescription drugs, over-the-counter products, and a pipeline aimed at addressing future medical needs.

Recent filings

Filing Released Lang Actions
지속가능경영보고서등관련사항(자율공시)
Report Publication Announcement Classification · 75% confidence The document is a short voluntary disclosure (1,906 chars) summarizing the company’s 2026 Sustainability (ESG) Report, providing metadata (title, verification body, standards, scope, link to website) and referring to attached materials. It does not include substantive ESG data or full report content—rather it announces and links to the report. Under the “menu vs. meal” rule (documents under 5,000 characters that state a report is attached or linked), this should be classified as a Report Publication Announcement (RPA).
2026-06-01 Korean
[기재정정]투자판단관련주요경영사항 (유방암 치료제 탁소텔(Taxotere)의 글로벌 비즈니스 인수 계약의 건)
M&A Activity Classification · 75% confidence The document is a Korean corporate disclosure titled “투자판단 관련 주요경영사항” detailing an amendment to the terms (정정신고) of a business acquisition contract for the global rights to the Taxotere brand. It is not a financial report or earnings release but an M&A transaction announcement/update. This aligns with “M&A Activity (Code: TAR)” which covers announcements and documents related to merger proposals or takeover bids. Therefore it is classified as TAR.
2026-06-01 Korean
기업지배구조보고서공시
Governance Information Classification · 92% confidence The document is a detailed corporate governance report (“기업지배구조보고서 신고서”) describing board composition, governance policies, compliance with key governance indicators, committees, and shareholder meeting procedures. It is not merely an announcement or proxy statement but the full governance information report, matching the Governance Information category.
2026-05-29 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 93% confidence The document is titled “분기보고서” (Quarterly Report) for the period 2026-01-01 to 2026-03-31, containing detailed company overview, business description, consolidated financial statements, notes, management analysis, audit opinion, and extensive financial tables. It is a full interim/quarterly report with actual financial data, not merely an announcement or summary. This fits the definition of an Interim / Quarterly Report (IR). Q1 2026
2026-05-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is titled '주식등의 대량보유상황보고서' which translates to 'Report on Large Shareholding Status'. It details the ownership percentages, changes in shareholdings, special relationships, and contracts related to shareholdings. It includes specific dates, share counts, and explanations of changes such as mergers and share transfers. The document is a regulatory filing related to disclosure of major shareholdings and changes thereof, consistent with notifications required under capital market laws. It is not an annual report, earnings release, or management report. It is not a proxy statement or voting result announcement. It is a detailed notification of changes in significant share ownership levels, fitting the definition of Major Shareholding Notification (MRQ). The document length is over 11,000 characters and contains substantive data, so it is not a mere announcement or report publication notice.
2026-05-06 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' which translates to 'Report on Ownership Status of Specific Securities by Executives and Major Shareholders.' It contains detailed information about share ownership changes, including dates, share counts, ownership percentages, and reasons for changes such as mergers. It is addressed to regulatory bodies like the Securities and Futures Commission and the Korea Exchange. This matches the description of a Major Shareholding Notification, which reports changes in significant share ownership levels. The document length is 2724 characters, which is consistent with a detailed notification rather than a brief announcement or a full financial report. Therefore, the correct classification is Major Shareholding Notification (MRQ).
2026-05-06 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.